| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |